HNGE
Hinge Health, Inc.
98.40$
+0.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +5.5% | -2.6% | +11.0% | -3.3% | -2.1% | +13.5% | |
| – | – | – | – | – | – | +9.5% | -3.2% | +10.1% | -19.0% | -5.3% | +27.3% | |
| – | – | – | – | – | – | -4.7% | -17.8% | +10.2% | -20.4% | -9.6% | +52.2% | |
| – | – | -0.6% | – | – | – | +0.5% | -12.2% | +16.2% | -24.2% | -12.8% | +22.7% | |
| – | – | – | – | – | – | +78.6% | +30.8% | -12.6% | -23.9% | +74.0% | +9.1% | |
| – | – | – | – | – | – | -48.7% | +9.4% | -1.3% | +13.2% | +130.4% | -53.4% | |
| – | – | – | – | – | – | +4.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | +76.3% | -7.0% | -7.6% | -8.2% | -9.0% | -9.8% | |
| – | – | -314.8% | – | – | – | +5.8% | +16.9% | +13.1% | +1.2% | +13.9% | +15.8% | |
| – | – | – | – | – | – | +7.3% | +17.4% | +13.7% | +1.5% | +14.4% | +16.2% | |
| – | – | – | – | – | – | +2.2% | +3.8% | +3.3% | +1.0% | +0.3% | +0.5% | |
| – | – | – | – | – | – | – | – | +52.4% | +7.8% | +21.2% | -12.6% | |
| – | – | +0.0% | – | – | – | +5.3% | -14.9% | +9.2% | -7.2% | -17.7% | +10.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +17.8% | -15.1% | +0.0% | +0.0% | +0.0% | +1.1% | +7.2% | -2.5% | -0.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.